UTILIZATION OF ATOMOXETINE AND OTHER PHARMACOTHERAPY IN YOUTHS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER IN MEDICAID PATIENTS IN 29 US STATES

被引：0
|
作者：
Linden, S. [1 ]
Knox, C. [1 ]
Winterstein, A. [1 ]
机构：
[1] Univ Florida, Gainesville, FL 32610 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [41] PHARMACOTHERAPY FOR CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    PELHAM, WE
    SCHOOL PSYCHOLOGY REVIEW, 1993, 22 (02) : 199 - 227
  • [42] Pharmacotherapy of attention-deficit/hyperactivity disorder in adults
    Wender, PH
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 76 - 79
  • [43] Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder
    Vaughan, Brigette
    Kratochvil, Christopher J.
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 21 (04) : 941 - +
  • [44] Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder
    Kollins, Scott H.
    March, John S.
    BIOLOGICAL PSYCHIATRY, 2007, 62 (09) : 951 - 953
  • [45] Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder
    Geller, Daniel
    Donnelly, Craig
    Lopez, Frank
    Rubin, Richard
    Newcorn, Jeffrey
    Sutton, Virginia
    Bakken, Rosalie
    Paczkowski, Martin
    Kelsey, Douglas
    Sumner, Calvin
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (09): : 1119 - 1127
  • [46] Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder
    Diler, Rasim Somer
    Daviss, W. Burleson
    Lopez, Adriana
    Axelson, David
    Lyengar, Satish
    Birmaher, Boris
    JOURNAL OF AFFECTIVE DISORDERS, 2007, 102 (1-3) : 125 - 130
  • [47] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder
    Bangs, Mark E.
    Hazell, Philip
    Danckaerts, Marina
    Hoare, Peter
    Coghill, David R.
    Wehmeier, Peter M.
    Williams, David W.
    Moore, Rodney J.
    Levine, Louise
    PEDIATRICS, 2008, 121 (02) : E314 - E320
  • [48] PHARMACOKINETIKS OF ATOMOXETINE IN PLASMA AND ORAL FLUID IN PEDIATRIC PATIENTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER
    Papaseit, E.
    Garcia-Algar, O.
    Aznar, G.
    Marchei, E.
    Pacifici, R.
    Pichini, S.
    Farre, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E16 - E16
  • [49] Efficacy and Safety Limitations of Attention Deficit Hyperactivity Disorder Pharmacotherapy in Pediatric Patients
    Wigal, Sharon B.
    JOURNAL OF PEDIATRICS, 2009, 154 (05): : S13 - S21
  • [50] Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
    Childress, Ann C.
    Sallee, Floyd R.
    CNS DRUGS, 2015, 29 (08) : 683 - 693
12345